IT1251615B - Medicamento ad attivita' antielastasica. - Google Patents

Medicamento ad attivita' antielastasica.

Info

Publication number
IT1251615B
IT1251615B ITMI912652A ITMI912652A IT1251615B IT 1251615 B IT1251615 B IT 1251615B IT MI912652 A ITMI912652 A IT MI912652A IT MI912652 A ITMI912652 A IT MI912652A IT 1251615 B IT1251615 B IT 1251615B
Authority
IT
Italy
Prior art keywords
antielastasic
medication
activity
activity medication
preparation
Prior art date
Application number
ITMI912652A
Other languages
English (en)
Inventor
Gerardo Bernasconi
Original Assignee
Golgi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golgi Sa filed Critical Golgi Sa
Priority to ITMI912652A priority Critical patent/IT1251615B/it
Publication of ITMI912652A0 publication Critical patent/ITMI912652A0/it
Priority to JP5506603A priority patent/JPH06506500A/ja
Priority to EP92920465A priority patent/EP0565658A1/en
Priority to CA002097611A priority patent/CA2097611A1/en
Priority to PCT/EP1992/002269 priority patent/WO1993006823A1/en
Priority to AU26644/92A priority patent/AU2664492A/en
Publication of ITMI912652A1 publication Critical patent/ITMI912652A1/it
Application granted granted Critical
Publication of IT1251615B publication Critical patent/IT1251615B/it

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Si descrive l'uso di un derivato terpenico per la preparazione di un medicamento utile nel trattamento dell'enfisema polmonare.
ITMI912652A 1991-10-04 1991-10-04 Medicamento ad attivita' antielastasica. IT1251615B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (it) 1991-10-04 1991-10-04 Medicamento ad attivita' antielastasica.
JP5506603A JPH06506500A (ja) 1991-10-04 1992-09-30 肺気腫に対して抗エラスターゼ活性を有するベルベノン
EP92920465A EP0565658A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
CA002097611A CA2097611A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase actibity, against pulmonary emphysema
PCT/EP1992/002269 WO1993006823A1 (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema
AU26644/92A AU2664492A (en) 1991-10-04 1992-09-30 Verbenone, having antielastase activity, against pulmonary emphysema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912652A IT1251615B (it) 1991-10-04 1991-10-04 Medicamento ad attivita' antielastasica.

Publications (3)

Publication Number Publication Date
ITMI912652A0 ITMI912652A0 (it) 1991-10-04
ITMI912652A1 ITMI912652A1 (it) 1993-04-04
IT1251615B true IT1251615B (it) 1995-05-17

Family

ID=11360822

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912652A IT1251615B (it) 1991-10-04 1991-10-04 Medicamento ad attivita' antielastasica.

Country Status (6)

Country Link
EP (1) EP0565658A1 (it)
JP (1) JPH06506500A (it)
AU (1) AU2664492A (it)
CA (1) CA2097611A1 (it)
IT (1) IT1251615B (it)
WO (1) WO1993006823A1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
ES2673853T3 (es) * 2012-06-05 2018-06-26 Korea University Research And Business Foundation Composición farmacéutica que contiene un derivado de verbenona para tratar o prevenir una enfermedad neurodegenerativa
CN113603802B (zh) * 2021-08-24 2022-10-14 华侨大学 一种马鞭草多糖的制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH625197A5 (en) * 1976-06-03 1981-09-15 Buskine Sa Process for preparing verbenone, myrtenal and pinocarveol
EP0491812A4 (en) * 1989-09-14 1992-11-04 Australian Commercial Research & Development Limited Drug delivery compositions

Also Published As

Publication number Publication date
CA2097611A1 (en) 1993-04-04
WO1993006823A1 (en) 1993-04-15
EP0565658A1 (en) 1993-10-20
AU2664492A (en) 1993-05-03
JPH06506500A (ja) 1994-07-21
ITMI912652A1 (it) 1993-04-04
ITMI912652A0 (it) 1991-10-04

Similar Documents

Publication Publication Date Title
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
IT1240360B (it) Uso di un derivato dell'1alfa-idrossivitamina d per la preparazione di un medicamento per il trattamento dell' iperparatiroidismo
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
NO954694L (no) Doseringsform for antidepressiva
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
BR9509975A (pt) Formulação farmacêutica
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
IT1251838B (it) Uso della nimesulide nel trattamento della cataratta
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
NO954952L (no) Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
IT1251615B (it) Medicamento ad attivita' antielastasica.
HUP9801686A2 (hu) Amino-tetralin-származék alkalmazása kardiovaszkuláris megbetegedések terápiájában használható gyógyszer előállítására
DK0487613T3 (da) Megakarycytopiesk faktor
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
IT1245369B (it) Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
IT8740155A0 (it) Estensione dell'uso di un prodotto farmaceutico alimentare curativo
IT8821369A0 (it) Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971029